Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00327067 · ClinicalTrials.gov registry record
Iron Replacement in Blood Donors
A clinical trial of Iron-deficiency, sponsored by National Institutes of Health Clinical Center (CC).
- Completed
- Registry status
- 1,820
- Enrollment target
- 1
- Study location
NCT00327067 is a study of Iron-deficiency that has completed, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 1,820 participants, above the 85-participant average among 16 other Iron-deficiency trials with a reported enrollment target (2041% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00327067, a study of Iron-deficiency, has completed, sponsored by National Institutes of Health Clinical Center (CC).
- COMPLETED
- Registry status
- 1,820 participants
- Enrollment target
- 1
- Study location
Study Summary
Blood donors who have a low fingerstick hemoglobin level are usually deferred from donating. A possible solution to the problem of repeated deferrals might be for Blood Banks to offer donors with low hemoglobin levels oral iron supplements. To determine the feasibility of such a program, this study will: * Determine the frequency of iron deficiency in first-time and repeat blood donors * Examine the effects of long-term blood donation on donor hemoglobin levels and iron stores * Compare body iron stores in donors who have low hemoglobin values with that of donors who have acceptable hemoglobin values at the time of donation * Determine what conditions other than iron deficiency lead to low hemoglobin levels in blood donors * Determine the safety and effectiveness of giving oral iron tablets to donors with low hemoglobin levels * Monitor the effect of oral iron administration on donor satisfaction and donor retention. First-time and repeat blood donors at the NIH Clinical Center Blood Bank 18 years of age and older may be eligible for this study. Participants include prospective donors who have an acceptable hemoglobin value at the time of donation and those whose hemoglobin level is determined to be too low for donation. All participants do the following: * Answer medical questions about their diet, health, and family history of blood disorders. * Have blood samples drawn from their arm for testing blood cell counts, iron stores, and other hemoglobin-related tests as appropriate. Donors with low hemoglobin also: * Take iron supplements (ferrous sulfate) to replenish iron stores. (Donors who have previously had unpleasant side effects from ferrous sulfate are offered ferrous gluconate as an alternative.) * Undergo evaluation with medical screening and laboratory tests at the time of future blood donations.
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center, 9000 Rockville Pike - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,820 participants |
| Start Date | 2006-05-12 |
| Est. Completion | 2012-03-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00327067
The ClinicalTrials.gov registry entry for NCT00327067 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,820 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 85-participant average among 16 other Iron-deficiency trials with a reported enrollment target (2041% higher). The listed sponsor is National Institutes of Health Clinical Center (CC), which has 338 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Iron-deficiency appearing as the primary indexed condition, and to 0 interventions.
NCT00327067 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00327067 about?
NCT00327067 is a clinical study titled "Iron Replacement in Blood Donors". Blood donors who have a low fingerstick hemoglobin level are usually deferred from donating. A possible solution to the problem of repeated deferrals might be for Blood Banks to offer donors with low hemoglobin levels oral iron supplements. To determine the feasibility of such a program, this study ...
What is the current status of trial NCT00327067?
This trial is currently completed. The enrollment target is 1,820 participants. The study started on 2006-05-12. Estimated completion is 2012-03-01.
What conditions does trial NCT00327067 study?
This clinical trial studies the following conditions: Iron-deficiency.
Who is sponsoring clinical trial NCT00327067?
This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00327067 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Iron-deficiency
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants
RECRUITING · Phase 2
-
Impact of Intravenous Iron Repletion On Mechanisms of Exercise InTolerance in HFpEF (IRONMET-HFpEF)
RECRUITING · Phase 4
-
IRONICA: IRON Repletion In Heart Failure - A Comparison of Oral and IV Approaches
RECRUITING · Phase 4
-
IntraVenous Iron in Kids With Iron Deficiency and Scoliosis Study
RECRUITING · Phase 2
-
A Randomized Placebo Controlled Pilot Study of Probiotic Supplementation in At-risk Pregnant Women
COMPLETED · NA
-
Effect of Iron Supplements on the Growth of Enteric Pathogens
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.